by Daniel X. Thomas
The patent relates to the prevention and treatment of secondary infections following viral infection, particularly in infants and small children.
Brief outline of the case
The patent was maintained in opposition according a MR.
The opponent appealed the decision.
The board decided that claim 1 as maintained was lacking IS.
by Daniel X. Thomas
The patent relates to prodrugs of phosphonate nucleotide analogues and methods for selecting and making same.
Brief outline of the case
The patent results from a divisional application of EP01961695 / EP 1 301 519.
The OD decided maintenance according to AR 6.
All three opponents appealed this decision.
by Daniel X. Thomas
The patent relates to micronised crystalline tiotropium bromide. The corresponding application is a divisional of EP 03708206/EP 1 487 832.
Brief outline of the case
The four opponents have appealed the rejection of their oppositions. Eventually one opponent was left.
The board confirmed the rejection of the remaining opposition.
by Daniel X. Thomas
The patent relates to a fabric treatment composition, exactly to a softener.
Brief outline of the case
Opponent 2 appealed the decision to reject the opposition.
In appeal there was a long discussion about experimental data submitted by all the parties. Those data were all post-published.
There was unanimity among the parties that D1=DE 10 2006 034 051,
by Daniel X. Thomas
The patent relates to a “Tablet formulation of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide for use in the treatment of cystic fibrosis”.
Brief outline of the case
The OD decided maintenance according to AR 16 as the claims as granted and AR 1-15 where lacking sufficiency.
The opponent appealed the decision of the OD.